Protein digestion and metabolism have been studied in laboratory rats and miniature pigs to investigate the mechanisms of action of lactulose and lactitol when used in the treatment of patients with portosystemic encephalopathy.
Lactulose
(13-D-galactopyranosyl-(1-*4)-,3-Dfructofuranose) has been used in the treatment of portosystemic encephalopathy, a common complication of cirrhosis of the liver, ever since the pioneering experiments of Bircher et al. ' Its action is not fully understood, however, but several hypotheses have been suggested, all of which focus mainly on events in the lower gut. Conn and Lieberthal have listed five theories2: bacteria ferment lactulose to organic acids, and the acidity produced encourages a more favourable gut flora; this acidity, and the osmotic effects of lactulose, have beneficial cathartic effects; the acidity inhibits production of ammonia by bacteria; the acidified luminal contents trap ammonia; lactulose stimulates bacterial growth and thereby the incorporation of luminal ammonia, and possibly ammonia from body tissue, into bacterial protein.
There is evidence from animal studies that any carbohydrate which reaches the lower gut has a considerable stimulatory effect on bacterial activity and growth, and hence on the quantity and type of faecal nitrogen.3 Lactulose is not hydrolysed by human gut enzymes4 and as it is not absorbed in the small intestine2 it reaches the lower gut. In patients with cirrhosis there is increased faecal nitrogen output when lactulose is given5 and this may be important in understanding its action. Mason has suggested that the use of lactulose in the treatment of portosystemic encephalopathy may depend on it providing an energy source for bacteria in the lower gut, and he suggested some alternatives which may be superior.6 Such bacterial growth uses the nitrogenous components of the luminal contents which would otherwise be absorbed into the systemic circulation, overloading the body's capacity to metabolise them, and leading to the neurological effects that characterise portosystemic encephalopathy.2
Lactulose syrup has to be prescribed in such large amounts (30-150 ml or more, equivalent to 20-100 g lactulose) that it can be regarded as a dietary supplement rather than a drug, but it is by no means ideal as a food ingredient. Sub In all experiments a cross over design with two periods was used in which each animal received the following dietary treatments. a control diet, without lactitol or lactulose syrup, and an experimental diet including one of these supplements. The animals were assigned to each of two groups by a random process. One group received the experimental diet in the first period and the control diet in the second; the other group was given the diets in the reverse order.
DIETS
The pigs were fed on a normal pig diet whereas the rats were given a semipurified diet based on casein and maize starch.'3 The levels of lactulose and lactitol tested varied as shown in Table I . Lactitol was incorporated in the control diet for rats at the expense of maize starch at the level of 100 g/kg. For pigs, the same amount of lactitol (100 g) was added to each kg of control diet. Rats would not tolerate this amount of lactulose and thus 75 gfkg was used. Pigs tolerated lactulose in the diet and animals were given as much as they would take while still producing semisolid faeces that could be collected separately from the urine.
NUTRITIONAL BALANCE STUDIES
During the balance periods complete collections of urine and faeces were made corresponding accurately to particular feeding periods. Urine was collected into 005 M sulphuric acid to reduce losses of volatile nitrogenous substances. Samples were freeze dried before further processing.'3 All faeces and urine collections were analysed for nitrogen while the collections from the first group of conventional rats given lactulose were also analysed for a-,r-diaminopimelic acid.
ANALYTICAL METHODS
Nitrogen was determined by a micro-Kjeldahl method. To determine a-,E-diaminopimelic acid, protein hydrolysis was followed by purification of the acid on an anionic exchange resin and colorimetric estimation after reaction with ninhydrin. ' being increased by 33% to 83%, nitrogen in the urine being reduced by 7% to 34%. All effects were significant apart from lactitol on urinary nitrogen in the miniature pig. Table II shows the amounts of the bacterial amino acid a-,e-diaminopimelic acid in the faeces of rats on the control and the lactulose containing diets. With lactulose syrup in the diet the concentration in the faeces was about five times greater, and the total amount excreted was increased about six times compared with the control value.
In an experiment on germ free and conventional rats the effects of adding lactulose syrup to the diet of the conventional animals (shown in Table III ) were similar to those previously observed (Table I) , though the absolute values were higher. In the germ free rats, however, the effect on faecal nitrogen was completely reversed and a significant interaction between diet and environment was clearly established. In contrast, lactulose syrup had no effect on the nitrogen excreted in the urine by germ free animals.
Discussion
Currently the standard treatment for portosystemic encephalopathy is 100 g lactulose/day, or roughly 160 g/kg of food dry matter. Our criterion for giving rats and pigs the doses used in these studies was the same as a doctor's -that is, maximum intake without precipitating diarrhoea. The amount given varied from 160 to 310 g/kg of dry matter or up to twice the amount a patient may consume. The maximum dose we used is not vastly greater than the human dose and appeared to be physiologically equivalent. Unfortunately, lactulose has been available only as a sickly sweet syrup that is rather disliked. Nevertheless, it has proved reliably successful. A complete understanding of how it works is desirable since such knowledge could offer the prospect of developing suitable alternatives of greater acceptability to patients.
The first effect after consuming lactulose is probably catharsis, and indeed it is used successfully to treat constipation. Lactulose reaches the lower gut unchanged where it is metabolised by bacteria to short chain fatty acids'7 with a consequent lowering of pH'8 and thereby having a further cathartic effect. It would be expected that lactulose consumption would lead to considerable changes in the bacterial flora of the lower gut, but despite much study the picture is confused.2
The current work was done in normal healthy animals to clarify one aspect of the physiological effects of lactulose -that is, the effect on the excretion of the nitrogenous end products of protein digestion and metabolism. In our studies dietary supplements of both lactulose and lactitol increased the amount of nitrogen in the faeces and there was a concomitant, and generally greater, reduction in urinary nitrogen. In Weber's patients lactulose increased faecal nitrogen by 125 mg/g food nitrogen and urinary nitrogen was decreased by 85 mg/g food nitrogen. 5 Thus in these respects the normal healthy rat and pig responded similarly to portosystemic encephalopathy patients.
Evidence that giving lactulose involved the gut flora was obtained by estimating faecal bacteria by measuring a-,e-diaminopimelic acid. This amino acid has been used as a marker for bacterial nitrogen in studies of ruminant nutrition'9 since it is present only in bacteria, though not in all species, and not in protozoa and plant material. (Rumen bacteria contained 4-6 mg a-,e-diaminopimelic acid/g dry cells. '9) Giving lactulose syrup to rats led to a considerable increase in the amount of this amino acid excreted, suggesting an increase in the number of bacteria in the faeces. The ratio of a-, c-diaminopimelic acid to nitrogen in bacteria varies widely, however, and it is possible that a treatment effect could arise from an alteration in the composition of the bacterial flora rather than from a change in the total number of bacteria. Nevertheless, the effect observed was so pronounced that it seems likely that there was an increase in the bacterial content of the faeces. Recently, Weber and coworkers assessed the effect of lactulose on faecal material directly.20 They applied a physical method of quantitative separation to patients' faeces and showed that lactulose increased both the bacterial nitrogen and, surprisingly, the non-bacterial soluble nitrogen components of the excreta. The effect on the bacteria confirms our results, though the experiments are not directly comparable due to the possible effects of the different diet types used. The experiment with germ free rats provided further support for the involvement of the gut flora. It sould be pointed out, however, that there are differences between germ free and conventional animals which should be borne in mind in interpreting comparative results. Most importantly, there is the peculiar enlargement of the caecum and lower gut and the related physiological characteristics of germ free rodents. Differences in the efficiency ofprotein utilisation have been reported before, and we found that germ free rats on the control diet lost about a third more nitrogen than conventional rats. Similar observations, of a 22% increase21 and of a 20-50% increase (Z Ofuya et al, personal communication) have been made; these effects may be due to the absence of the deaminating activity of bacteria in the germ free animals. In contrast to the effect of lactulose in conventional animals this treatment caused an appreciable decrease in faecal nitrogen in germ free rats, suggesting the possibility of some counteraction of the effect of the lack of a gut flora. The absence of any positive effect on faecal nitrogen supports the idea that the effect of lactulose in conventional animals is mediated through the gut flora.
These results support the hypothesis that lactulose is effective in the treatment of portosystemic encephalopathy because it stimulates bacterial growth in the lower digestive tract. This conclusion may, however, be simplistic. The bacterial population in the gut is extremely complex in type and number so the result of any treatment is likely to be complicated. Our results do not exclude the possibility that other treatments that act by means of the gut flora, such as antibiotics, may bring additional benefit above that due to undigested carbohydrates such as lactulose. Antibiotics rarely remove all bacteria as is the case in the germ free animal, and in patients treated with appropriate antibiotics there will often remain scope for treatment with indigestible carbohydrates. The clinical evidence for additive effects of one such antibiotic, neomycin, and lactulose is equivocal. 22 The gut flora can differ substantially between individuals and so too does individual tolerance to substances like lactulose. It seems reasonable to suppose, however, that appropriate antibiotics may usefully supplement lactulose treatment when substantial numbers of 'harmful' bacteria are unaffected by treatment with lactulose or when the patient will not consume enough lactulose for complete control of the metabolic activity of the gut flora.
It seems that lactitol has a similar effect to lactulose syrup. Further work is required to confirm that these sugars act simply as energy sources for the growth of bacteria in the gut and do not have other specific actions that depend on their chemical structure. 
